 Rocky Baker
Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 18 | 2025 | 1095 | 3.110 |
Why?
| | Autoantigens | 12 | 2022 | 428 | 2.430 |
Why?
| | Diabetes Mellitus, Type 1 | 21 | 2025 | 3710 | 2.050 |
Why?
| | Insulin | 10 | 2025 | 2406 | 1.790 |
Why?
| | Chromogranin A | 7 | 2024 | 42 | 1.640 |
Why?
| | C-Peptide | 6 | 2025 | 163 | 1.630 |
Why?
| | Islets of Langerhans | 7 | 2025 | 803 | 1.360 |
Why?
| | Islet Amyloid Polypeptide | 4 | 2018 | 46 | 1.190 |
Why?
| | T-Lymphocytes | 4 | 2025 | 1998 | 0.980 |
Why?
| | Mice, Inbred NOD | 15 | 2022 | 601 | 0.810 |
Why?
| | Autoimmunity | 7 | 2022 | 908 | 0.740 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2021 | 187 | 0.740 |
Why?
| | CD40 Antigens | 2 | 2012 | 89 | 0.650 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2021 | 721 | 0.620 |
Why?
| | Peptides | 9 | 2024 | 982 | 0.580 |
Why?
| | Autoantibodies | 1 | 2025 | 1500 | 0.540 |
Why?
| | Recombination, Genetic | 1 | 2018 | 199 | 0.540 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2021 | 194 | 0.530 |
Why?
| | Peptide Fragments | 6 | 2024 | 707 | 0.490 |
Why?
| | CD40 Ligand | 2 | 2012 | 41 | 0.450 |
Why?
| | Lymphocyte Activation | 4 | 2018 | 1150 | 0.430 |
Why?
| | Epitopes | 5 | 2024 | 480 | 0.380 |
Why?
| | Prediabetic State | 1 | 2013 | 253 | 0.330 |
Why?
| | Cells, Cultured | 7 | 2019 | 4197 | 0.320 |
Why?
| | Mice | 17 | 2024 | 17774 | 0.310 |
Why?
| | Adoptive Transfer | 3 | 2015 | 224 | 0.310 |
Why?
| | Clone Cells | 3 | 2018 | 266 | 0.260 |
Why?
| | Animals | 19 | 2024 | 36862 | 0.250 |
Why?
| | Specific Pathogen-Free Organisms | 2 | 2018 | 60 | 0.240 |
Why?
| | Antigens, CD | 1 | 2008 | 522 | 0.240 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 372 | 0.230 |
Why?
| | Mice, SCID | 2 | 2018 | 367 | 0.230 |
Why?
| | Mice, Knockout | 4 | 2021 | 3009 | 0.210 |
Why?
| | HLA-DQ Antigens | 2 | 2021 | 181 | 0.200 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2022 | 64 | 0.180 |
Why?
| | Flow Cytometry | 3 | 2015 | 1184 | 0.180 |
Why?
| | K562 Cells | 1 | 2021 | 89 | 0.180 |
Why?
| | Protein Array Analysis | 1 | 2021 | 57 | 0.170 |
Why?
| | HLA-DRB1 Chains | 1 | 2020 | 112 | 0.160 |
Why?
| | Graft Survival | 1 | 2022 | 534 | 0.150 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2019 | 137 | 0.150 |
Why?
| | Crosses, Genetic | 1 | 2018 | 137 | 0.150 |
Why?
| | Immunotherapy | 2 | 2021 | 641 | 0.140 |
Why?
| | Immune System | 1 | 2019 | 177 | 0.140 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2012 | 2516 | 0.140 |
Why?
| | Nanoparticles | 2 | 2022 | 484 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 1 | 2019 | 664 | 0.130 |
Why?
| | Female | 8 | 2025 | 73052 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 558 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 387 | 0.130 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1269 | 0.130 |
Why?
| | Young Adult | 2 | 2025 | 13163 | 0.120 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 168 | 0.120 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 460 | 0.110 |
Why?
| | Adolescent | 3 | 2025 | 21499 | 0.110 |
Why?
| | Disease Progression | 2 | 2019 | 2752 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2015 | 5753 | 0.110 |
Why?
| | Insulin, Regular, Human | 2 | 2024 | 43 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2019 | 2479 | 0.100 |
Why?
| | Child | 3 | 2025 | 21999 | 0.100 |
Why?
| | CD4 Antigens | 1 | 2013 | 142 | 0.100 |
Why?
| | Male | 5 | 2025 | 67560 | 0.100 |
Why?
| | Humans | 10 | 2025 | 137294 | 0.100 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 368 | 0.090 |
Why?
| | Transduction, Genetic | 1 | 2012 | 126 | 0.090 |
Why?
| | Spleen | 1 | 2013 | 514 | 0.090 |
Why?
| | Pancreas | 1 | 2013 | 329 | 0.090 |
Why?
| | Lymph Nodes | 1 | 2013 | 493 | 0.090 |
Why?
| | Adult | 3 | 2025 | 37724 | 0.080 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 397 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2015 | 846 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 916 | 0.080 |
Why?
| | CD28 Antigens | 1 | 2008 | 53 | 0.080 |
Why?
| | CTLA-4 Antigen | 1 | 2008 | 99 | 0.070 |
Why?
| | Signal Transduction | 2 | 2012 | 5078 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4164 | 0.070 |
Why?
| | Up-Regulation | 1 | 2008 | 844 | 0.060 |
Why?
| | Immune Tolerance | 2 | 2019 | 362 | 0.060 |
Why?
| | Proinsulin | 1 | 2024 | 52 | 0.050 |
Why?
| | Middle Aged | 1 | 2025 | 33310 | 0.050 |
Why?
| | Cathepsin D | 1 | 2022 | 18 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2841 | 0.050 |
Why?
| | Transglutaminases | 2 | 2013 | 156 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2016 | 2147 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2164 | 0.050 |
Why?
| | Proteomics | 2 | 2022 | 1108 | 0.050 |
Why?
| | Cytoprotection | 1 | 2021 | 56 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1431 | 0.050 |
Why?
| | Drug Liberation | 1 | 2021 | 36 | 0.040 |
Why?
| | Click Chemistry | 1 | 2021 | 49 | 0.040 |
Why?
| | Solubility | 1 | 2021 | 247 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 216 | 0.040 |
Why?
| | Remission Induction | 1 | 2021 | 288 | 0.040 |
Why?
| | Cross Reactions | 1 | 2020 | 133 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1059 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 190 | 0.040 |
Why?
| | Animals, Genetically Modified | 1 | 2019 | 240 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 362 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 790 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2013 | 126 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2013 | 171 | 0.030 |
Why?
| | Chromatography, Gel | 1 | 2012 | 127 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2016 | 2904 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 156 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4284 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1501 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 739 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 10800 | 0.020 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|